Stock: Apple (NASDAQ: AAPL)
Stock Rating: BUY
Price Target: N/A
Market Price: $116.03
Research Publication Date: 11/25/20
Time to buy Apple (AAPL) stock? We think so. The fundamental backdrop heading into the release of the first 5G iPhone hasn’t been as rosy given the weakened economic environment due to the absence of stimulus payments, but it doesn’t change the fact that this year’s line-up is the best we’ve seen in a number of years.
We anticipate that iPhone refresh will be significant, as the design of the iPhone 12 reminds us of the iPhone 5S but just bigger and better with much beefier components. For those who remember how popular iPhone 5 and 5S was… we can only imagine the iPhone 12 toppling expectations on unit sales given the reintroduction of a design that caters to iPhone loyalists at a time when Apple needed to deliver the most.
If design is not a compelling enough reason, we anticipate that 5G could also bring customers back despite the gloomy outlook heading into the holiday season. Consensus estimates suggests revenue of $101.88B for Q4’20 vs. Q4’19 sales of $88.5B. Some pundits believe expectations have gotten so elevated to the point where a sales miss is in the cards… and the price could drop. However, we think demand will likely surprise on consumer hardware given the softened expectations tied to last quarter’s quarterly miss, and the absence of quarterly revenue guidance (which we will discuss further in the next section).
Source: Google Finance
What about expectations?
We anticipate that Apple’s stock is mostly consolidating into a tight trading range on the condition that the company is able to deliver above expectations in the upcoming quarter. Bears may suggest that expectations seem too elevated. But, with refresh likely suggesting hardware revenue growth, and software/services revenue continuing to grow at a steady pace, its unlikely that an expectation miss will create an opportunity to buy Apple stock at an even cheaper price.
Luca Maestri (CFO of Apple):
Given the continued uncertainty around the world in the near term, we will not be issuing revenue guidance for the coming quarter. However, we are providing some insights on our expectations for the December quarter for our product categories. These directional comments assume that COVID related impacts to our business in November and December are similar to what we’re seeing in October.
So, coming out of last quarter, analysts were given every reason not to make aggressive sales estimates. The key for shareholders heading into the next year isn’t profitability, but the topline revenue figure, which is why the release of this year’s 5G iPhone hasn’t translated to an expectation lift, and as such we’re positioned for one of the most unique holiday quarter’s we’ve seen in a while.
Analyst estimates will be based purely on financial models absent of any internal data provided by Apple’s management. This gives analysts like us every reason to make conservative estimates on both hardware and software revenue. Therefore, its more likely that Apple’s decision to not report outlook is precisely why they will end up beating on revenue and earnings estimates.
Particularly revenue growth of 15% y/y sounds borderline crazy when compared to other points in iPhone’s history, but we genuinely believe that this year’s iPhone can actually carry the company and diminish some of the dependency on software/services we’ve seen in the past several years.
Furthermore, we think the recent pullback to $110-$115 creates a compelling re-entry point before analysts come back with early channel check data. Meaning that prior to analysts revising up on strengthening data points within the supply chain, the recent pullback creates an opportunity to buy the dip just one more time before the stock starts recovering and starts pushing $130-$150.
Disclosure: Cho Research was not compensated by Apple to publish “Buy Apple (AAPL) On The Dip Because We’re Going Back Up” Though Cho Research does use the research dollars it generates from other clients of our research service to fund market research
reports such as this along with advertising. Cho Research may at its sole discretion enter into a position following the publication of this report. This document is not produced in conjunction with a security offering and is not an offering to purchase securities. This report
does not consider individual circumstances and does not take into consideration
individual investor preferences. Recipients of this report should consult
professionals around their personal situation, including taxation. Statements
within this report may constitute forward-looking statements, these statements
involve many risk factors and general uncertainties around the business,
industry, and macroeconomic environment. Investors need to be aware of the high
degree of risk in micro capitalization equities, cryptocurrencies, crypto assets.
Independent equity research isn’t regulated by the SEC and operates separately from more conventional sell-side equity research. The publication of independent equity research is unregulated and rules pertaining to published independent equity research are covered under “freedom of the press” with legal case precedent taken all the way to the N.Y. Supreme Court to guard against libel based claims or claims of loss relating to the publication of a report on a company. Any copyright claim relating to infringement is covered under fair use of copyrighted materials. Since the use of material was derived into a separate form of analysis without any substantial content derived from any third-party no copyright claim can be pursued under common law. To discuss investment risk or to consider the risks pertaining to any securities it is recommended to consult a registered financial advisor. To understand independent research it’s encouraged to read this published article on independent equity research to become more familiar with industry standard practices and the relative value of independent equity research versus brokerage research and news media.Cho Research, its subsidiaries, and employees may open along/short equity position at future date from the data of publication of the report. The price per share and trading volume of subject company and companies referenced in this report may fluctuate and Cho Research is not liable for these inherent market fluctuations. The past performance of this investment is not indicative of the future performance, no returns are guaranteed, and a loss of capital may occur. Certain transactions, such as those involving futures,options, and other derivatives, can result in substantial risk and are not suitable for all investors.